Insider Transactions in Q3 2021 at Adverum Biotechnologies, Inc. (ADVM)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Julie Clark Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,766
-2.81%
|
$9,532
$2.17 P/Share
|
|
Aug 06
2021
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
680,000
+49.05%
|
-
|
|
Aug 06
2021
|
Peter Soparkar CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
220,000
+48.81%
|
-
|
|
Aug 06
2021
|
Angela Thedinga Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+50.0%
|
-
|
|
Aug 06
2021
|
Julie Clark Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+41.45%
|
-
|